Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,027,751
  • Shares Outstanding, K 227,752
  • Annual Sales, $ 1,526 M
  • Annual Income, $ -41,460 K
  • 60-Month Beta 0.36
  • Price/Sales 7.27
  • Price/Cash Flow 18.33
  • Price/Book 4.23

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.56
  • Number of Estimates 1
  • High Estimate 0.56
  • Low Estimate 0.56
  • Prior Year 0.36
  • Growth Rate Est. (year over year) +55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.87 +6.40%
on 07/14/20
50.97 -4.25%
on 07/29/20
+3.57 (+7.90%)
since 07/13/20
3-Month
41.98 +16.25%
on 05/15/20
50.97 -4.25%
on 07/29/20
+5.95 (+13.89%)
since 05/13/20
52-Week
25.04 +94.90%
on 10/09/19
50.97 -4.25%
on 07/29/20
+12.92 (+36.02%)
since 08/13/19

Most Recent Stories

More News
Medtronic (MDT) Plans $160 Million R&D Investment in India

The newest expansion plan of MEIC will help Medtronic (MDT) advance in the field of pain alleviation and restoration of health.

MDT : 101.22 (-0.85%)
PKI : 119.95 (+0.07%)
QGEN : 48.73 (+0.64%)
TMO : 416.22 (+0.01%)
Press release from Davidson Kempner regarding Qiagen

, /PRNewswire/ -- is pleased that the majority of investors have rejected the wholly inadequate offer made by Thermo Fisher Scientific. The low acceptance level of 47.02% is a clear signal that there...

QGEN : 48.73 (+0.64%)
QIAGEN to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation After Voluntary Public Takeover Offer Falls Short

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it will continue to execute its successful growth strategy aiming to create significant value for shareholders and other stakeholders...

QGEN : 48.73 (+0.64%)
TMO : 416.22 (+0.01%)
Medtronic Plans New Acquisition in AI-Driven Diabetes Care

Medtronic's (MDT) acquisition of Companion Medical aims to expand service to diabetics using multiple daily injections for diabetes management.

MDT : 101.22 (-0.85%)
QGEN : 48.73 (+0.64%)
TMO : 416.22 (+0.01%)
TNDM : 98.37 (+1.16%)
Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement

, /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its offer to acquire all of the ordinary shares of QIAGEN N.V. (NYSE: QGEN; Frankfurt...

DB : 9.56 (-1.54%)
QGEN : 48.73 (+0.64%)
TMO : 416.22 (+0.01%)
Thermo Fisher Scientific Provides Process Overview for the Announcement of Final Offer Results

Thermo Fisher Scientific Inc. , the world leader in serving science, today provided an overview of the process to report the final results from the acceptance period of its offer to acquire all of the...

QGEN : 48.73 (+0.64%)
TMO : 416.22 (+0.01%)
Thermo Fisher Scientific Provides Process Overview for the Announcement of Final Offer Results

, /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today provided an overview of the process to report the final results from the acceptance period of its...

QGEN : 48.73 (+0.64%)
TMO : 416.22 (+0.01%)
HTG Molecular Diagnostics Announces New Commercialization and Distribution Agreement for Companion Diagnostics with QIAGEN

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signing of a Commercialization and Distribution Agreement...

QGEN : 48.73 (+0.64%)
HTGM : 0.5350 (-0.93%)
Assessment of the Global Biomarkers Industry, Forecast to 2026 and the Impact of COVID-19

, /PRNewswire/ -- The report has been added to offering.

ABT : 101.03 (+0.38%)
ENZ : 2.49 (+1.22%)
MKKGY : 27.2900 (-0.11%)
PKI : 119.95 (+0.07%)
QGEN : 48.73 (+0.64%)
QIAGEN (QGEN) Q2 Earnings In Line With Estimates, Margins Up

QIAGEN (QGEN) registered robust revenue growth across majority of geographies and both operating segments in Q2 despite the coronavirus-led economic crisis.

HOLX : 68.12 (+0.19%)
QGEN : 48.73 (+0.64%)
TMO : 416.22 (+0.01%)
WST : 275.30 (+1.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade QGEN with:

Business Summary

Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

See More

Key Turning Points

2nd Resistance Point 48.98
1st Resistance Point 48.70
Last Price 48.73
1st Support Level 48.19
2nd Support Level 47.96

See More

52-Week High 50.97
Last Price 48.73
Fibonacci 61.8% 41.06
Fibonacci 50% 38.01
Fibonacci 38.2% 34.95
52-Week Low 25.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar